HIGHLIGHTS
- who: Retinal Vein Occlusion from the Department of Ophthalmology, Cantonal Hospital Aarau, Aarau, Switzerland Department of Ophthalmology, Inselspital, University Hospital of Bern and University of Bern, Bern, Switzerland have published the research work: Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion, in the Journal: (JOURNAL) of 29/08/2016
- what: The aim of this study was to quantify the percentage of low-responders. The aim of this study was to analyze data of "real-life" patients outside a clinical trial setting to identify and differentiate low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.